Related Experiment Video

Updated: Jun 24, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

250

Prognosis of synchronous endometrial and ovarian cancer based on the PROMISE molecular system

Ming Wang1, Yue Li, Jianqing Xu

  • 1Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing 100006, China.

Chinese Medical Journal
|June 13, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.7K

Related Experiment Videos

Last Updated: Jun 24, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

250
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.7K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer Survival Analysis01:21

Cancer Survival Analysis

343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343

Articles linked to this work by shared authors, journal, and citation graph.

Enhancing stability and function of induced regulatory T cells through membrane-anchored transforming growth factor-β1 and interleukin-10 secretion to protect against graft-vs-host disease.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026

KREMEN1 residue W94 is essential for receptor binding and infection by a major group of enteroviruses.

mBio·2026

SLC3A2 promotes early-stage of Zika virus infection in human placental cells and astrocytes.

Infectious diseases & immunity·2026

Tumor-draining lymph nodes shape the tumor microenvironment through enrichment of tumor-reactive effector-exhausted CD8+ T cells.

Signal transduction and targeted therapy·2026

Discovery and Structural Characterization of a Highly Protective Neutralizing Antibody Targeting the Mpox Virus A35R Protein.

MedComm·2026

AI-aided design of multi-epitope peptide vaccine elicits cellular and humoral immunity to broad Omicron subvariants.

Zoological research·2026

Effect of transcutaneous auricular vagus nerve stimulation on perioperative psychological symptoms in patients undergoing elective thoracoscopic lung resection: A randomized controlled trial.

Chinese medical journal·2026

Mesenchymal stem cells in diabetic kidney disease: Potential regulatory mechanisms and related signaling pathways of mesenchymal stem cells.

Chinese medical journal·2026

ESR1 alterations in breast cancer: Mechanisms, detection, and therapeutic implications.

Chinese medical journal·2026

Chronic obstructive pulmonary disease increases the risk of cardiovascular disease occurrence in nonsmokers: A nationwide cohort study.

Chinese medical journal·2026

Interleukin-33 alleviates the immunosuppressive tumor microenvironment and enhances anti-programmed death ligand-1 immunotherapy efficacy in hepatocellular carcinoma.

Chinese medical journal·2026

Extracellular vesicles as biomarkers and therapeutic nanocarriers in cancer.

Chinese medical journal·2026

P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy by Age After PCI: A SHARE Substudy.

JACC. Asia·2026

Does Prior Androgen Exposure Alter Outcomes After Gynecomastia Surgery? A Propensity-Matched Analysis.

The American surgeon·2026

Risk-adapted MRI Protocols for the Detection of Clinically Significant Prostate Cancer.

Radiology. Imaging cancer·2026

Multimodal Transformer Integrating CT and Pathology for Postoperative Risk Stratification in Stage I Non-Small Cell Lung Cancer.

Radiology. Imaging cancer·2026

Evaluation of programmed death ligand 1 (PD-L1) expression and CD8+ T-cell immune response in primary pterygium.

Indian journal of ophthalmology·2026

Severity at the Gates: Or Why Prevention is the Aim of Reproductive Genetic Carrier Screening.

The American journal of bioethics : AJOB·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us